- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Kodak exits ultrasound miniPACS market
After several unsuccessful attempts to divest its ultrasound miniPACS operations, Eastman Kodak has opted to shut down this business to focus on its full-scale PACS products. Rochester, NY-based Kodak quietly announced in early October that all sales and
After several unsuccessful attempts to divest its ultrasound miniPACS operations, Eastman Kodak has opted to shut down this business to focus on its full-scale PACS products. Rochester, NY-based Kodak quietly announced in early October that all sales and manufacturing of its Access ultrasound miniPACS, ImageVue echocardiography image management system, and Kodak G4 image and information management system would cease by years end.
Service and support for these products will continue until the company has transitioned existing customers to other sources or products. The number of employees affected by the discontinued operations is very minor, according to Nancy Sousa, vice president of new business for Kodaks health imaging division.
Kodak originally got into the ultrasound miniPACS business through a 1994 partnership with Nova Microsonics, then an Allendale, NJ-based subsidiary of ATL Ultrasound (SCAN 2/1/95). Nova developed both ImageVue and Access, which Kodak integrated into its PACS product line. Kodak then acquired Nova Microsonics in 1997 (SCAN 2/19/97), after ATL determined that it was not interested in providing the broad-based image management solutions many of its ultrasound customers were clamoring for.
But Kodaks acquisition of Cemax-Icon last year as part of Imations medical imaging business (SCAN 12/16/98) has led to a change in the companys image management strategy. Since completing the Imation deal, Kodak has consolidated all of its PACS business into Cemax-Icon (SCAN 3/3/99) but felt that trying to integrate the ultrasound products into Cemax as well was not the best decision, according to Sousa.
In addition, both Kodak and Cemax had determined that the growth of the ultrasound miniPACS market has been moderate at best, according to Gary Larson, president of Fremont, CA-based Cemax-Icon.
The main impact on Cemax is that we now have greater resources to devote to our enterprise-wide PACS business, Larson said.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
